South Dakota Senate Bill SB24

South Dakota 2022 Regular Session

• Introduced: 1/11/22
• Refer: 1/11/22
• Report Pass: 1/19/22
• Engrossed: 2/7/22
• Refer: 2/15/22
• Report Pass: 3/1/22
• Enrolled: 3/2/22
• Passed: 3/28/22

Caption

Establish a maximum number of cannabis plants that may be cultivated by a medical cannabis cardholder.

Impact

The bill amends existing statutes related to cannabis use and comprehensive regulations concerning medical cannabis. By establishing caps on cultivation, SB24 not only helps maintain oversight but also prevents the potential for abuse by cardholders. Additionally, it aims to outline the types of medical conditions that qualify for the use of cannabis, thereby tightening definitions and standards. This could lead to a more coherent and manageable implementation of the medical cannabis program throughout South Dakota.

Summary

Senate Bill 24 is legislation introduced in the state of South Dakota that seeks to establish a framework for the cultivation of cannabis by medical cannabis cardholders. This bill specifies a maximum number of cannabis plants that a registered cardholder can cultivate—specifically, two flowering plants and two non-flowering plants. This measure is designed to regulate and standardize the growing of cannabis, ensuring that it remains within controlled limits while providing access for patients with qualifying medical conditions.

Sentiment

The sentiment surrounding SB24 appears to be cautiously supportive among medical practitioners who recognize the therapeutic benefits of cannabis for patients dealing with severe conditions. However, there are also concerns about limiting patient access and the adequacy of the amount of cannabis that can be cultivated for personal medical use. Discussions among legislators indicate a division regarding the balance between regulation and accessibility, especially when weighing patient rights against potential misuse.

Contention

Notable points of contention surrounding SB24 include the definitions of debilitating conditions and the limitations imposed on cultivation. Critics argue that the specified limits may not suffice for patients requiring cannabis for chronic conditions, leading to fears of inadequate supply for those needing it for consistent therapeutic use. There is also discussion about ensuring that the law remains accessible and practical for those who genuinely need cannabis for medical reasons, not just those with a medical card.